CDMO News
Bayer and Evotec Join Forces to Develop Innovative CVD Therapies
Bayer and Evotec announced on 30 April 2024 that they have updated the focus of their strategic collaboration. The new focus is on developing innovative precision treatments for cardiovascular diseases (CVDs), a leading cause of death globally. The collaboration aims to
2 May 2024